Premium Supplement NMN KIWAMI Made in Japan with FDA Compliance Seeks Strategic U.S. Distribution Partnerships
Clinically validated with confirmed telomere lengthening and used in Japanese medical institutions and IV therapies, this product supports distributor wellness portfolios with a 95% repeat rate. Japan, 3rd Mar 2026 – Asa Pharmaceutical Co., Ltd. (Headquarters: Minato Ward, Tokyo; President and CEO: Tomoko Iwase), a manufacturer and distributor of health supplements, announced that effective Monday,…